Skip to main contentAI and Advanced
/
HEALTHX · NSEBSE SENSEX74,294.96-0.03%BSE |
NIFTY 5023,346.4+0.33%NSE |
NIFTY BANK56,358.7+0.54%NSE |
NIFTY IT28,854.55-1.03%NSE |
NIFTY AUTO27,129-0.11%NSE |
NIFTY FMCG45,466.8-0.23%NSE |
NIFTY PHARMA26,710.1+0.49%NSE |
NIFTY 50022,840.55+0.82%NSE |
HE
NSE · Equity shares · Computer Services5.00 · 1.67%
Health X Platform Ltd HEALTHX
NSE:INR 305
BSE:INR 291.3
Data quality and coveragePrice, company fundamentals and optional research feeds are tracked separately.
Headline priceLast market snapshot
Company fundamentalsStale · last-known data
Research sections9 of 9 availableMissing source values remain unavailable, never zero-filled.
AI analysis and Advanced tools for HEALTHX
Analysis, reports, chat and Advanced access use the same Rusaka Markets account. The backend remains authoritative for roles, subscriptions, credits and permissions.
Snapshot
Price and key statistics
Reported and computed values remain separate; missing values are not converted to zero.
Previous closeINR 300
Day rangeINR 294 — INR 319
52-week rangeINR 252.5 — INR 375
Volume1,400
Market cap1,017.94
P/E694.46
Fundamental highlightsReported values unless marked as computed
Revenue (INR Cr)1,319.27
Net Income (INR Cr)1.18
Rev Growth (5 Year %)19.2
P/E Ratio694.46
Book Value190.08
EPS0.6
Price/BV1.60Computed
Research path: Interpret Health X Platform Ltd's snapshot alongside the wider market dashboard, the financial-statement research guide and the valuation-ratios field guide.
Validated OHLC
Interactive price chart
Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.
HEALTHXHealth X Platform Ltd1d · INR · NSE
Loading validated candles…
Auditable calculations
Daily technical summary
Calculated from validated daily candles. Descriptive research only.
Calculating technicals…
Indicators describe price behaviour and volatility; they are not a BUY, NEUTRAL or SELL recommendation.
Company reporting
Financial statements
IND AS · INR crore
| Metric | 2026 | 2025 | 2024 |
|---|---|---|---|
| Total Liabilities Shareholders' Equity | 935.77 | 974.37 | 1,149.59 |
| Cash Equivalents | 30.22 | Not available | Not available |
| Other Liabilities Total | 48.17 | 23.11 | 13.37 |
| Long Term Debt | 22.09 | Not available | Not available |
| Common Stock Total | 31.81 | 31.81 | 31.81 |
| Total Assets | 935.77 | 974.37 | 1,149.59 |
| Total Equity | 640.89 | 669.87 | 762.37 |
| Long Term Investments | 520.9 | 591.18 | 784.38 |
| Retained Earnings(Accumulated Deficit) | 609.08 | 499.08 | 591.58 |
| Total Common Shares Outstanding | 3.18 | 3.18 | 3.18 |
| Tangible Book Valueper Share Common Eq | 190.08 | 199.19 | 228.28 |
| Goodwill Net | 36.14 | 36.14 | 36.14 |
| Total Liabilities | 294.88 | 304.5 | 387.22 |
| Total Debt | 25.66 | 0.92 | 3.88 |
| Cashand Short Term Investments | 30.22 | 12.42 | 33.61 |
| Total Receivables Net | 7.66 | 13.8 | 44.02 |
| Deferred Income Tax | 5.43 | 3.97 | 67.64 |
| Accounts Receivable-Trade Net | 7.66 | 10 | 43.48 |
| Property/Plant/Equipment Total-Net | 79.37 | 73.6 | 71.96 |
| Minority Interest | 124.38 | 194.66 | 237.16 |
| Total Inventory | 144.65 | 110.29 | 115.79 |
| Accounts Payable | 86.02 | 58.75 | 42.54 |
| Other Currentliabilities Total | 5.22 | 16.73 | 18.45 |
| Total Long Term Debt | 25.66 | 0.92 | 3.88 |
| Other Assets Total | 82.99 | 84.23 | 24.49 |
| Intangibles Net | 0.1 | 0.08 | 0.06 |
| Other Long Term Assets Total | 13.84 | 11.33 | 0.41 |
| Note Receivable-Long Term | 19.91 | 40.71 | 38.06 |
| Capital Lease Obligations | 3.56 | 0.92 | 3.88 |
| Accumulated Depreciation Total | Not available | -35.22 | -30.95 |
| Accrued Expenses | Not available | 6.36 | 4.18 |
| Prepaid Expenses | Not available | 0.56 | 0.69 |
| Additional Paid-In Capital | Not available | 138.98 | 138.98 |
| Cash | Not available | 12.42 | 33.61 |
| Property/Plant/Equipment Total-Gross | Not available | 108.82 | 102.9 |
| Notes Payable/Short Term Debt | Not available | 0 | 0 |
Fundamentals
Valuation and ratios
Growth
Debt 5Yr CAGR %15.48
Margins
Operating Margin 12m-4.54
Operating Margin 5y Avg4.6
Net Profit Margin 12m-0.11
Net Profit Margin 5y15.04
Yield
Dividend Yield %0
Valuation
Price to Sale Ratio0.77
Risk and consensus
Source-qualified signals
Risk metrics
Overall RiskBalanced risk
Board Risk37.82
Analyst consensus
Analyst consensus unavailable.
Provider consensus uses a 1 (Strong Buy) to 5 (Strong Sell) score. The payload does not include price targets, so none are inferred from 52-week prices or recommendation percentages.Industry context
Peer comparison
Only peers present in the company profile payload are displayed.
| Company | Price | Market cap | P/E | Research |
|---|---|---|---|---|
| Eternal | INR 285.85 | 2.76 L | 734.87 | — |
| Wipro | INR 174.45 | 1.73 L | 13.59 | — |
| Info Edge (India) | INR 1,189.4 | 77,123.15 | 43.95 | — |
| Tata Technologies | INR 718.9 | 29,191.06 | 49.34 | — |
| Netweb Technologies India | INR 4,310 | 24,565.45 | 116.92 | — |
Shareholding
Ownership
- Promoter
- 74.07%
- FII
- 2.29%
- Other
- 23.64%
Company intelligence
Latest relevant news
Source, timestamp and external destination are shown. Provider relevance scores are not available.
Obi marks 65th birthday with N10m Anambra hospital donation - The Guardian Nigeria NewsMarket news · 20 Jul 2026, 9:10 am
Obi marks 65th birthday with N10m Anambra hospital donation The Guardian Nigeria News
OncoSil Medical Limited (ASX:OSL) Establishes Australian Manufacturing Platform Ahead of Commercial Production - KalkineMarket news · 13 Jul 2026, 8:34 am
OncoSil Medical Limited (ASX:OSL) Establishes Australian Manufacturing Platform Ahead of Commercial Production Kalkine
One Health platform strengthens zoonotic disease surveillance across multiple domains - News-MedicalMarket news · 13 Jul 2026, 8:10 am
One Health platform strengthens zoonotic disease surveillance across multiple domains News-Medical
Virinchi approves ₹100 crore healthcare business acquisition - scanx.tradeMarket news · 12 Jul 2026, 12:30 pm
Virinchi approves ₹100 crore healthcare business acquisition scanx.trade
Battery X Metals Presents Positive Preliminary Lithium-Ion Battery Rebalancing Trial Results Demonstrating Significant Estimated Driving Range Improvements and Accelerated Commercialization Progress of its Patent-Pending Lithium-Ion Battery Rebalancin - Newswire.comMarket news · 11 Jul 2026, 5:30 am
Battery X Metals Presents Positive Preliminary Lithium-Ion Battery Rebalancing Trial Results Demonstrating Significant Estimated Driving Range Improvements and Accelerated Commercialization Progress of its Patent-Pending Lithium-Ion Battery Rebalancin Newswire.com
NANO-X IMAGING LTD - Via RitzauMarket news · 7 Jul 2026, 5:40 pm
NANO-X IMAGING LTD Via Ritzau
Corporate actions
Events
- board MeetingsAudited Results
- annual General MeetingPOM
- board MeetingsQuarterly Results
- board MeetingsQuarterly Results
- annual General MeetingAGM
- annual General MeetingPOM
- board MeetingsQuarterly Results
- board MeetingsAudited Results
Rusaka Markets Community
Discussion and sentiment for Health X Platform Ltd
Posts are linked to the canonical company record. Community BUY, NEUTRAL and SELL opinions are user-generated, moderated and separate from analyst consensus and Rusaka Markets AI.
Checking your Rusaka Markets account…
Company profile
Business information
What the company does
Health X Platform Limited, formerly Sastasundar Ventures Limited, is an India-based company, which is engaged in the business of digital networks of healthcare and portfolio management services. The Company's segments include Financial Services and Healthcare Network. The Financial Services segment consists mainly of financing of loans and investment in shares and securities, financial consultancy, professional fees, wealth management, financial planning, distribution, and related services. The Health Network segment includes activities for pathology, food processing and marketing of healthcare and over-the-counter products through e-commerce portal and diagnostic services, which consist of pathological/radiological investigations. Its digital platforms for healthcare include consumer-focused digital healthcare platform consisting of pharmacy, diagnostics and wellness, and a business to business (B2B) digital platform for pharmaceutical and wellness products.
Company facts
- Industry
- Computer Services
- Sector
- Computer Services
- NSE Code
- HEALTHX
- BSE Code
- 533259
Questions
Stock FAQ
What is the symbol and ISIN of Health X Platform Ltd?
Health X Platform Ltd has the symbol HEALTHX and ISIN - INE019J01013.
What is the current price of Health X Platform Ltd?
Health X Platform Ltd is currently trading at INR 305.00.
What are the year high and year low of Health X Platform Ltd?
Health X Platform Ltd has a year high of INR 375.00 and a year low of INR 252.50.
What is the market capitalization of Health X Platform Ltd?
Health X Platform Ltd has a market capitalization of INR 1,017.94 crore.
What is the P/E ratio of Health X Platform Ltd?
Health X Platform Ltd has a P/E ratio of 694.46.
What is the dividend yield of Health X Platform Ltd?
Health X Platform Ltd has a dividend yield of 0.00%.
How is the financial performance of Health X Platform Ltd based on revenue, net income, and EPS?
Health X Platform Ltd has revenue of INR 1,319.27 crore, net income of INR 1.18 crore, and EPS of INR 0.60.
What is the book value of Health X Platform Ltd?
Health X Platform Ltd has a book value of INR 190.08.
What is the debt-to-equity ratio of Health X Platform Ltd?
Health X Platform Ltd has a debt-to-equity ratio of NA.
What are the price-to-book and price-to-sales ratios of Health X Platform Ltd?
Health X Platform Ltd has a price-to-book ratio of 1.60 and a price-to-sales ratio of 0.77.
Corporate-action adjustment is provider-defined. Rusaka Markets research and computed indicators are not investment advice.